Skip to main content
. 2014 Dec 10;7(6):665–671. doi: 10.1016/j.tranon.2014.09.007

Table 2.

Histologic Assessment of Proliferative and Apoptotic Activity of Tumor Cells. Histologic Assessment Was Performed for the Tumors Collected at the End of the Treatment. Results Are Shown as Fold Changes of Mean for Each Group in Comparison with Control. Arrows Indicate an Increase (Arrow Up) or Decrease (Arrow Down) of Proliferative or Apoptotic Activity in Treated Tumors versus Respective Controls

All Models SW872 UZLX-STS3 UZLX-STS5
Proliferative activity
 H&E
 DOX ↓1.3 ↓1.3 ↓1.7 1.0
 PAZ ↓2.2⁎⁎## ↓2.1⁎⁎## ↓2.5⁎⁎# ↓1.7⁎#
 PAZ + DOX ↓2.0⁎⁎## ↓1.8⁎⁎## ↓2.3⁎⁎# ↓2.4⁎##
 pHH3
 DOX ↓1.2 ↑1.1 ↓1.5 ↓1.2
 PAZ ↓1.9⁎⁎# ↓2.0⁎⁎## ↓1.8 ↓1.6
 PAZ + DOX ↓1.9⁎# ↓2.0⁎⁎## ↓1.9 ↓1.2
 Ki67
 DOX 1.0 1.0 ↑1.2 1.0
 PAZ ↓1.2⁎# ↓1.2 ↓1.2# ↓1.2
 PAZ + DOX ↓1.5⁎⁎## ↓1.3⁎⁎# ↓2.7⁎⁎## 1.0
Apoptotic activity
 H&E
 DOX ↑1.1 1.0 ↑1.7 1.0
 PAZ ↑1.4 ↑1.4 ↑2.2⁎⁎ 1.0
 PAZ + DOX ↑1.6 ↑1.3 ↑2.2⁎⁎ ↑3.0
 CC3
 DOX ↑1.1 1.0 ↑1.3 ↑2.0
 PAZ ↑1.3 ↑1.1 ↑1.7⁎⁎ 1.0
 PAZ + DOX ↑1.3 1.0 ↑1.6⁎⁎ ↑4.0

Statistical significance was calculated using Mann-Whitney U test.

Compared to control: *P < .05, **P < .005; compared to DOX: #P < .05, ##P < .005.

H&E, hematoxylin and eosin staining; pHH3, phospho-histone H3 immunostaining; CC3, cleaved caspase-3 immunostaining.